Wellgistics Health, Inc. (NASDAQ: WGRX) Stock Competitors & Peer Comparison
See WGRX's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Distribution Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for WGRX and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| WGRX | $3.52 | +0.00% | 8.7M | -0.33 | -$10.55 | N/A |
| MCK | $863.20 | +1.11% | 98.2B | 20.55 | $40.82 | +0.39% |
| COR | $319.18 | +0.66% | 61.2B | 18.35 | $17.15 | +0.76% |
| CAH | $228.91 | -2.53% | 53.5B | 21.90 | $10.43 | +0.89% |
| ABC | $179.98 | -0.23% | 36.1B | 21.92 | $8.21 | N/A |
| HSIC | $88.47 | -0.92% | 10.1B | 16.66 | $5.31 | N/A |
| PDCO | $31.33 | +0.00% | 2.8B | 20.48 | $1.53 | +2.49% |
| PBH | $50.93 | -1.45% | 2.4B | 11.43 | $4.42 | N/A |
| OMI | $2.68 | +8.94% | 207.1M | -0.47 | -$5.69 | N/A |
| ACH | $1.24 | -6.44% | 99.9M | 1.92 | $0.68 | N/A |
Stock Comparison
McKesson Corporation (NYSE: MCK)
WGRX vs MCK Comparison August 2026
Wellgistics Health, Inc. (NASDAQ: WGRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGRX stands at 8.7M. In comparison, MCK has a market cap of 98.2B. Regarding current trading prices, WGRX is priced at $3.52 on the NASDAQ, while MCK trades at $863.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGRX currently has a P/E ratio of -0.33, whereas MCK's P/E ratio is 20.55. In terms of profitability, WGRX's ROE is +8.78%, compared to MCK's ROE of -1.94%. Regarding short-term risk, WGRX is more volatile compared to MCK. This indicates higher risk in terms of short-term price fluctuations for WGRX.Check MCK's competition here
Cencora, Inc. (NYSE: COR)
WGRX vs COR Comparison August 2026
Wellgistics Health, Inc. (NASDAQ: WGRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGRX stands at 8.7M. In comparison, COR has a market cap of 61.2B. Regarding current trading prices, WGRX is priced at $3.52 on the NASDAQ, while COR trades at $319.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGRX currently has a P/E ratio of -0.33, whereas COR's P/E ratio is 18.35. In terms of profitability, WGRX's ROE is +8.78%, compared to COR's ROE of +1.06%. Regarding short-term risk, WGRX is more volatile compared to COR. This indicates higher risk in terms of short-term price fluctuations for WGRX.Check COR's competition here
Cardinal Health, Inc. (NYSE: CAH)
WGRX vs CAH Comparison August 2026
Wellgistics Health, Inc. (NASDAQ: WGRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGRX stands at 8.7M. In comparison, CAH has a market cap of 53.5B. Regarding current trading prices, WGRX is priced at $3.52 on the NASDAQ, while CAH trades at $228.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGRX currently has a P/E ratio of -0.33, whereas CAH's P/E ratio is 21.90. In terms of profitability, WGRX's ROE is +8.78%, compared to CAH's ROE of -0.60%. Regarding short-term risk, WGRX is more volatile compared to CAH. This indicates higher risk in terms of short-term price fluctuations for WGRX.Check CAH's competition here
AmerisourceBergen Corporation (NYSE: ABC)
WGRX vs ABC Comparison August 2026
Wellgistics Health, Inc. (NASDAQ: WGRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGRX stands at 8.7M. In comparison, ABC has a market cap of 36.1B. Regarding current trading prices, WGRX is priced at $3.52 on the NASDAQ, while ABC trades at $179.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGRX currently has a P/E ratio of -0.33, whereas ABC's P/E ratio is 21.92. In terms of profitability, WGRX's ROE is +8.78%, compared to ABC's ROE of +1.06%. Regarding short-term risk, WGRX is more volatile compared to ABC. This indicates higher risk in terms of short-term price fluctuations for WGRX.Check ABC's competition here
Henry Schein, Inc. (NASDAQ: HSIC)
WGRX vs HSIC Comparison August 2026
Wellgistics Health, Inc. (NASDAQ: WGRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGRX stands at 8.7M. In comparison, HSIC has a market cap of 10.1B. Regarding current trading prices, WGRX is priced at $3.52 on the NASDAQ, while HSIC trades at $88.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGRX currently has a P/E ratio of -0.33, whereas HSIC's P/E ratio is 16.66. In terms of profitability, WGRX's ROE is +8.78%, compared to HSIC's ROE of +0.12%. Regarding short-term risk, WGRX is more volatile compared to HSIC. This indicates higher risk in terms of short-term price fluctuations for WGRX.Check HSIC's competition here
Patterson Companies, Inc. (NASDAQ: PDCO)
WGRX vs PDCO Comparison August 2026
Wellgistics Health, Inc. (NASDAQ: WGRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGRX stands at 8.7M. In comparison, PDCO has a market cap of 2.8B. Regarding current trading prices, WGRX is priced at $3.52 on the NASDAQ, while PDCO trades at $31.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGRX currently has a P/E ratio of -0.33, whereas PDCO's P/E ratio is 20.48. In terms of profitability, WGRX's ROE is +8.78%, compared to PDCO's ROE of +0.18%. Regarding short-term risk, WGRX is more volatile compared to PDCO. This indicates higher risk in terms of short-term price fluctuations for WGRX.Check PDCO's competition here
Prestige Consumer Healthcare Inc. (NYSE: PBH)
WGRX vs PBH Comparison August 2026
Wellgistics Health, Inc. (NASDAQ: WGRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGRX stands at 8.7M. In comparison, PBH has a market cap of 2.4B. Regarding current trading prices, WGRX is priced at $3.52 on the NASDAQ, while PBH trades at $50.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGRX currently has a P/E ratio of -0.33, whereas PBH's P/E ratio is 11.43. In terms of profitability, WGRX's ROE is +8.78%, compared to PBH's ROE of +0.09%. Regarding short-term risk, WGRX is more volatile compared to PBH. This indicates higher risk in terms of short-term price fluctuations for WGRX.Check PBH's competition here
Owens & Minor, Inc. (NYSE: OMI)
WGRX vs OMI Comparison August 2026
Wellgistics Health, Inc. (NASDAQ: WGRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGRX stands at 8.7M. In comparison, OMI has a market cap of 207.1M. Regarding current trading prices, WGRX is priced at $3.52 on the NASDAQ, while OMI trades at $2.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGRX currently has a P/E ratio of -0.33, whereas OMI's P/E ratio is -0.47. In terms of profitability, WGRX's ROE is +8.78%, compared to OMI's ROE of +0.63%. Regarding short-term risk, WGRX is more volatile compared to OMI. This indicates higher risk in terms of short-term price fluctuations for WGRX.Check OMI's competition here
Accendra Health, Inc. (NYSE: ACH)
WGRX vs ACH Comparison August 2026
Wellgistics Health, Inc. (NASDAQ: WGRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGRX stands at 8.7M. In comparison, ACH has a market cap of 99.9M. Regarding current trading prices, WGRX is priced at $3.52 on the NASDAQ, while ACH trades at $1.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGRX currently has a P/E ratio of -0.33, whereas ACH's P/E ratio is 1.92. In terms of profitability, WGRX's ROE is +8.78%, compared to ACH's ROE of +0.63%. Regarding short-term risk, WGRX is more volatile compared to ACH. This indicates higher risk in terms of short-term price fluctuations for WGRX.Check ACH's competition here
Akso Health Group (NASDAQ: HX)
WGRX vs HX Comparison August 2026
Wellgistics Health, Inc. (NASDAQ: WGRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGRX stands at 8.7M. In comparison, HX has a market cap of 53.4M. Regarding current trading prices, WGRX is priced at $3.52 on the NASDAQ, while HX trades at $2.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGRX currently has a P/E ratio of -0.33, whereas HX's P/E ratio is -1.84. In terms of profitability, WGRX's ROE is +8.78%, compared to HX's ROE of -1.07%. Regarding short-term risk, WGRX is more volatile compared to HX. This indicates higher risk in terms of short-term price fluctuations for WGRX.Check HX's competition here
111, Inc. (NASDAQ: YI)
WGRX vs YI Comparison August 2026
Wellgistics Health, Inc. (NASDAQ: WGRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGRX stands at 8.7M. In comparison, YI has a market cap of 29.8M. Regarding current trading prices, WGRX is priced at $3.52 on the NASDAQ, while YI trades at $3.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGRX currently has a P/E ratio of -0.33, whereas YI's P/E ratio is -2.44. In terms of profitability, WGRX's ROE is +8.78%, compared to YI's ROE of +0.14%. Regarding short-term risk, WGRX is more volatile compared to YI. This indicates higher risk in terms of short-term price fluctuations for WGRX.Check YI's competition here
ZeroStack Corp. (NASDAQ: ZSTK)
WGRX vs ZSTK Comparison August 2026
Wellgistics Health, Inc. (NASDAQ: WGRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGRX stands at 8.7M. In comparison, ZSTK has a market cap of 6.2M. Regarding current trading prices, WGRX is priced at $3.52 on the NASDAQ, while ZSTK trades at $5.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGRX currently has a P/E ratio of -0.33, whereas ZSTK's P/E ratio is -0.12. In terms of profitability, WGRX's ROE is +8.78%, compared to ZSTK's ROE of -3.82%. Regarding short-term risk, WGRX is more volatile compared to ZSTK. This indicates higher risk in terms of short-term price fluctuations for WGRX.Check ZSTK's competition here
DataMEDS AI, Inc. (NASDAQ: MEDS)
WGRX vs MEDS Comparison August 2026
Wellgistics Health, Inc. (NASDAQ: WGRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGRX stands at 8.7M. In comparison, MEDS has a market cap of 3.8M. Regarding current trading prices, WGRX is priced at $3.52 on the NASDAQ, while MEDS trades at $1.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGRX currently has a P/E ratio of -0.33, whereas MEDS's P/E ratio is N/A. In terms of profitability, WGRX's ROE is +8.78%, compared to MEDS's ROE of +8.78%. Regarding short-term risk, WGRX is more volatile compared to MEDS. This indicates higher risk in terms of short-term price fluctuations for WGRX.Check MEDS's competition here
Zynex, Inc. (NASDAQ: ZYXI)
WGRX vs ZYXI Comparison August 2026
Wellgistics Health, Inc. (NASDAQ: WGRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGRX stands at 8.7M. In comparison, ZYXI has a market cap of 3.8M. Regarding current trading prices, WGRX is priced at $3.52 on the NASDAQ, while ZYXI trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGRX currently has a P/E ratio of -0.33, whereas ZYXI's P/E ratio is -0.05. In terms of profitability, WGRX's ROE is +8.78%, compared to ZYXI's ROE of +11.38%. Regarding short-term risk, WGRX is more volatile compared to ZYXI. This indicates higher risk in terms of short-term price fluctuations for WGRX.Check ZYXI's competition here
Synergy CHC Corp. (NASDAQ: SNYR)
WGRX vs SNYR Comparison August 2026
Wellgistics Health, Inc. (NASDAQ: WGRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGRX stands at 8.7M. In comparison, SNYR has a market cap of 1.2M. Regarding current trading prices, WGRX is priced at $3.52 on the NASDAQ, while SNYR trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGRX currently has a P/E ratio of -0.33, whereas SNYR's P/E ratio is -0.08. In terms of profitability, WGRX's ROE is +8.78%, compared to SNYR's ROE of +0.91%. Regarding short-term risk, WGRX is more volatile compared to SNYR. This indicates higher risk in terms of short-term price fluctuations for WGRX.Check SNYR's competition here
Ridgetech, Inc. (NASDAQ: RDGT)
WGRX vs RDGT Comparison August 2026
Wellgistics Health, Inc. (NASDAQ: WGRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGRX stands at 8.7M. In comparison, RDGT has a market cap of 724.3K. Regarding current trading prices, WGRX is priced at $3.52 on the NASDAQ, while RDGT trades at $0.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGRX currently has a P/E ratio of -0.33, whereas RDGT's P/E ratio is -0.01. In terms of profitability, WGRX's ROE is +8.78%, compared to RDGT's ROE of -0.04%. Regarding short-term risk, WGRX is more volatile compared to RDGT. This indicates higher risk in terms of short-term price fluctuations for WGRX.Check RDGT's competition here
Covetrus, Inc. (NASDAQ: CVET)
WGRX vs CVET Comparison August 2026
Wellgistics Health, Inc. (NASDAQ: WGRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WGRX stands at 8.7M. In comparison, CVET has a market cap of 0. Regarding current trading prices, WGRX is priced at $3.52 on the NASDAQ, while CVET trades at $20.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WGRX currently has a P/E ratio of -0.33, whereas CVET's P/E ratio is -69.97. In terms of profitability, WGRX's ROE is +8.78%, compared to CVET's ROE of -0.06%. Regarding short-term risk, WGRX is more volatile compared to CVET. This indicates higher risk in terms of short-term price fluctuations for WGRX.Check CVET's competition here